BAK is a predictive and prognostic biomarker for the therapeutic effect of docetaxel treatment in patients with advanced gastric cancer
Tomohiro Kubo(Sapporo Medical University), Junji Kato(Sapporo Medical University)
Cited by 23
Related Papers
Combination of eribulin plus AKT inhibitor evokes synergistic cytotoxicity in soft tissue sarcoma cells
|Scientific Reports|2019|155
RNAi-mediated gene silencing of ST6GalNAc I suppresses the metastatic potential in gastric cancer cells
|Gastric Cancer|2014|47
The iron chelator deferasirox induces apoptosis by targeting oncogenic Pyk2/β-catenin signaling in human multiple myeloma
|Oncotarget|2016|44